Pulsaflox

RSS

difloxacin

Withdrawn
This medicine is now withdrawn from use in the European Union.

Overview

The marketing authorisation for Pulsaflox has been withdrawn at the request of the marketing authorisation holder.

This EPAR was last updated on 25/03/2010

Authorisation details

Product details
Name
Pulsaflox
Agency product number
EMEA/V/C/000060
Active substance
difloxacin
International non-proprietary name (INN) or common name
difloxacin
Species
  • Turkeys
  • Chicken
Anatomical therapeutic chemical veterinary (ATCvet) codes
QJ01MA
Publication details
Marketing-authorisation holder
Virbac S.A.
Revision
0
Date of issue of marketing authorisation valid throughout the European Union
16/11/2000
Contact address

1ère Avenue 2065 M - L.I.D.
06516 Carros Cedex
France

Product information

25/03/2010 Pulsaflox - EMEA/V/C/000060 -

Contents

  • Annex I - Summary of product characteristics
  • Annex IIA - Manufacturing-authorisation holder responsible for batch release
  • Annex IIB - Conditions of the marketing authorisation
  • Annex IIIA - Labelling
  • Annex IIIB - Package leaflet

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

Antibacterials for systemic use

Therapeutic indication

In chickens and turkeys Pulsaflox oral solution is indicated for treatment of chronic respiratory infections caused by sensitive strains of Escherichia coli and Mycoplasma gallisepticum.
In turkeys Pulsaflox oral solution is also indicated for the treatment of infections caused by Pasteurella multocida.
Pulsaflox oral solution should only be used based on susceptibility testing.

How useful was this page?

Add your rating